Shalala, Gaetz Seek to Reschedule Cannabis and Develop National Research Agenda
Reps. Donna Shalala, D-Fla., and Rep. Matt Gaetz, R-Fla., introduced the Expanding Cannabis Research and Information Act, bipartisan legislation that would facilitate research into the potential medical benefits and public health impacts of marijuana.
The bill would develop a national cannabis research agenda, direct the U.S. Department of Health and Human Services to collect data on the health impacts of cannabis, establish a National Institutes of Health “Centers of Excellence” research designation, and reclassify cannabis as a Schedule III controlled substance.
Currently, 11 states and the District of Columbia have legalized adult cannabis use, while 33 states have legalized medical cannabis use. However, the Drug Enforcement Administration continues to classify cannabis as a Schedule I controlled substance with no medical benefit.
The Expand Cannabis Research and Information Act would allow for a dramatic expansion in research around the health benefits and public safety impacts of cannabis use.
“For years now, states across the country have been liberalizing their cannabis laws without making corresponding investments in developing a better scientific understanding of the short and long-term benefits and effects of cannabis on human health,” Rep. Shalala said. “By rescheduling cannabis and directing our national research infrastructure to study and collect data on how it impacts health outcomes, we are not only bringing federal cannabis policy into the 21st century, but we’re also guaranteeing that we do so safely.”
“I am proud to work with Congresswoman Shalala on the Expanding Cannabis Research and Information Act,” Gaetz said. “This bipartisan and bicameral legislation will improve, expedite, and streamline cannabis research: by rescheduling cannabis to Schedule III, this bill will lessen the conflict between states and the federal government, and by designating “Centers of Excellence in Cannabis Research,” it will help unlock cures for America’s most vulnerable populations.”
In The News
Today, Wisconsin Gov. Tony Evers said the state has shipped its one-millionth N95 mask as part of ongoing efforts to ensure frontline workers have access to the critical personal protective equipment (PPE) they need to limit their exposure to COVID-19. The announcement comes after Evers recently... Read More
Efforts to speedily develop and distribute a coronavirus vaccine in the U.S. won't be derailed by a change in administration, said the head of Operation Warp Speed, the federal government's program aimed at accelerating a COVID-19 jab. "All decisions are made, the train is running. Whether one administration... Read More
NEW YORK — A COVID-19 vaccine may be months from reaching millions of Americans. Getting all those shots into arms will be a monumental task. Shreveport, Louisiana, is getting ready now. The city recently completed a test run, one of about a dozen across the state. Health officials... Read More
WASHINGTON — Front-line workers on Capitol Hill are continuing to contract COVID-19. Since the beginning of the coronavirus pandemic, 153 legislative branch employees have tested positive or are presumed positive for COVID-19, according to a Democratic aide for the House Administration Committee. This cumulative total, as of Nov. 18, includes 59... Read More
As health officials warn of the risks of Thanksgiving travel, more than half of Americans still plan to venture away from home, according to a new survey. The website Tripadvisor says 56% of people intend to take trips for the holiday this year, despite the coronavirus pandemic, a... Read More
WASHINGTON -- It is traditionally the largest travel holiday of the year, however, officials at the Centers for Disease Control and Prevention are urging Americans not to travel during this Thanksgiving holiday and to skip gatherings with family members outside their households. Officials with the agency... Read More